© Reuters. A completed GE digital anesthesia carestation stands as U.S. Vice President Mike Pence (not pictured) visits a GE Healthcare manufacturing facility during the global coronavirus disease (COVID-19) outbreak in Madison, Wisconsin, U.S. April 21, 2020. REUTE
(Reuters) – GE HealthCare Technologies Inc expects 2023 organic revenue growth to be in the range of 5% to 7%, the company said on Tuesday, citing robust customer demand, fulfillment of older orders, and improved pricing.
The forecast is in line with the company’s medium-term target of mid-single-digit organic revenue growth that it gave last month.
“While inflation remains a factor, we are seeing the supply chain environment continue to improve with demand for our products and services growing in 2023,” Chief Executive Officer Peter Arduini said in a statement.
GE HealthCare had garnered about $18.3 billion in revenue last year, according to preliminary data, with a 7% organic growth.
Be the first to comment